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Introduction
Covalent attachment of both myristic and palmitic acid to the
N-terminus of cellular proteins, most of which are involved
in signaling events, occurs more widely than previously
recognized (Dunphy and Linder, 1998; Resh, 1999). For
instance, the α subunits of heterotrimeric G proteins
(Milligan et al., 1995; Wedegaerten et al., 1995), the
myristoylated palmitoylated serine/threonine protein kinase
(MPSK) (Berson et al., 1999), endothelial nitric oxide
synthase (eNOS) (Robinson et al., 1995; Liu et al., 1995),
a-kinase anchoring protein 18 (AKAP18) (Fraser et al., 1998)
and members of the Src family of tyrosine kinases (Koegl et
al., 1994; Resh, 1994) are irreversibly acylated by myristic
acid and reversibly acylated by palmitic acid. Whereas
myristoylation occurs at the free amino group of the first Gly
residue resulting in the formation of an amide bond,
palmitoylation takes place through the formation of a
thioester bond with the side chain of an internal Cys residue.
The biochemistry of protein myristoylation, as well as the
properties of N-myristoyl transferase (the enzyme that
catalyzes the transfer of myristate from myristoyl-CoA to the
free amino group of a Gly residue of proteins), are well
understood (Bhatnagar et al., 1999). However, the
palmitoylation of previously myristoylated proteins at the
side chains of cysteine residues in proximity to the N-
terminus end of proteins is a less well understood process,
and both enzymatic and non-enzymatic mechanisms of
palmitic acid transfer have been proposed so far (Dunphy and
Linder, 1998; Resh, 1999). In the majority of the cases
studied to date, dually acylated proteins are regulated through
a palmitoylation-depalmitoylation cycle that correlates with
a transient association-dissociation from cholesterol-
sphingolipid-enriched subdomains present in the cellular
membrane (Milligan et al., 1995; Dunphy and Linder, 1998;
McCabe and Berthiaume, 1999; Simons and Toomre, 2000).
The partial purification of enzyme activities responsible for
palmitoylation of Gα subunits (Dunphy et al., 1996), N-Ras
(Liu et al., 1996b) and the C-terminal regions of Drosophila
Ras1 and Ras2 (Ueno and Suzuki, 1997) has been reported.
However, whereas the former enzymatic activity remains
elusive because of problems with cloning and molecular
characterization (Dunphy et al., 2001), the other two palmitoyl
transferase activities turned out to be a peroxisomal 3-
oxoacyl-CoA thiolase (Liu et al., 1996a) and a transferase that
did not depend upon the previous prenylation of the peptide
that was used as a substrate (Ueno and Suzuki, 1997), a feature
that is required for Ras palmitoylation in vivo (Hancock et al.,
1989).
3119
Using recursive PCR, we created an artificial protein
sequence that consists of a consensus myristoylation motif
(MGCTLS) followed by the triplet AGS repeated nine
times and fused to the GFP reporter. This linker-GFP
sequence was utilized as a base to produce multiple
mutants that were used to transfect COS-7 cells.
Constructs where a ‘palmitoylable’ cysteine residue was
progressively moved apart from the myristoylation site to
positions 3, 9, 15 and 21 of the protein sequence were made,
and these mutants were used to investigate the effect
of protein myristoylation on subsequent palmitoylation,
subcellular localization, membrane association and
caveolin-1 colocalization. In all cases, dual acylation of the
GFP chimeras correlated with translocation to Triton
X-100-insoluble cholesterol/sphingomyelin-enriched sub-
domains. Whereas a strong Golgi labeling was observed in
all the myristoylated chimeras, association with the plasma
membrane was only observed in the dually acylated
constructs. Taking into account the conflicting data
regarding the existence and specificity of cellular
palmitoyl-transferases, our results provide evidence that
de-novo-designed sequences can be efficiently S-acylated
with palmitic acid in vivo, strongly supporting the
hypothesis that non-enzymatic protein palmitoylation
can occur within mammalian cells. Additionally, this
palmitoylation results in the translocation of the
recombinant construct to low-fluidity domains in a
myristate-palmitate distance-dependent manner.
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Very recently, skinny Hedgehog (ski), a Drosophila
acyltransferase that is able to catalyze the palmitoylation of
Hedgehog (Hh), has been identified (Chamoun et al., 2001).
However, it has been reported that the palmitoyl group is
attached to the N-terminus of Hedhehog on the α amino group
of Cys-24 (Pepinsky et al., 1998). This attachment originates
through an autoproteolytic cleavage at an internal site during
which the bioactive N-terminal product of cleavage acquires
a C-terminally bound cholesterol molecule. Consequently, it
remains to be seen whether the mammalian orthologs of
this acyltransferase are able to catalyze the incorporation of
palmitic acid to other cellular targets.
Additional acyltransferase activities have been observed and
partially characterized in erythrocyte ghosts and placental
membranes (Das et al., 1997; Schmidt et al., 1995; Veit et al.,
1998) as well as in brain lysates (Berthiaume and Resh, 1995),
although all of them remain refractory to molecular cloning
and full characterization.
Conversely, Duncan and Gilman showed that palmitoyl-CoA
can stoichiometrically palmitoylate previously myristoylated
Giα1 in vitro in the absence of any cellular acyltransferase with
kinetics for the palmitoylation reaction that resemble those
described for palmitoylation in vivo (Duncan and Gilman,
1996). The non-enzymatic palmitoylation of Gsα at Cys3 was
also reported (Mollner et al., 1998). Magee and coworkers very
elegantly showed that myristoylated N-terminal peptides from
the Yesprotein tyrosine kinase, but not their non-myristoylated
counterparts, could be non-enzymatically palmitoylated by
palmitoyl-CoA in vitro (Bañó et al., 1998). The palmitoylation
reaction was pseudo-enzymatic in the sense that it depended
not only on the previous myristoylation of the substrate but also
on the length of the incubation period, the temperature and the
substrate concentration. Consequently, apparent Km and Vmax
values could be estimated for the peptide substrate. Other
examples of non-enzymatic acylation of proteins reported in
the literature include UDP-glucuronosyl transferase from
rat liver (Yamashita et al., 1995), the myelin proteolipid
(Bizzozero et al., 1987) and rhodopsin (O’Brien et al., 1987),
as well as cysteine-containing peptides (Quesnel and Silvius,
1994).
To investigate whether the cellular transfer of palmitate
from palmitoyl-CoA could occur in a de-novo-designed
protein sequence, we constructed a polypeptide where a
consensus N-myristoylation hexapeptide was followed by the
triplet Ala-Gly-Ser repeated nine times and fused to GFP. We
referred to this construct as ‘linker-GFP’. We avoided any
basic residue such as Lys or Arg within this sequence pattern
since that would also promote membrane targeting and raft
localization (McCabe and Berthiaume, 1999). Four of the Ser
residues in our construct, with a six-residue spacing within
them and located at different distances from the N-terminus,
were substituted by Cys residues (Fig. 1), and their
phenotypes were analyzed. Additionally, 12 residues were
introduced between the last cysteine residue that can be
putatively palmitoylated (Cys21) and the GFP sequence in
order to rule out the possibility that the three-dimensional
fold of the GFP might interfere with the palmitoylation
processes. Our data are consistent with the hypothesis that in
vivo palmitoylation of proteins can take place as long as a
reactive cysteine residue is in proximity to the cellular
membrane.
Materials and Methods
Cell culture and materials
COS-7 cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% foetal bovine serum (FBS), 100
u/ml penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine in a
5% CO2 atmosphere at 37°C. Transient transfection with the various
plasmids was performed using Superfect Transfection Reagent
(Qiagen) following the manufacturers’ instructions. The cells were
typically analyzed 36 hours post transfection. The Giα1-EGFP
(enhanced green fluorescent protein) construct was a generous gift
from Marco Parenti (University of Milano-Bicocca). It contains five
mutations (F64C, S65T, V163A, I167T and S175G) that result in
increased fluorescence emission. Anti-caveolin-1 antibodies were
obtained from Transduction Laboratories (Heidelberg, Germany)
(rabbit polyclonal and mouse monoclonal 2234). The anti-Gqα and
the anti-integrin β1 antibodies were from Calbiochem (Schwalbech,
Germany). The anti-5′-nucleotidase antibody was a gift from M. A.
Lizarbe (Complutense University, Madrid, Spain). A commercial anti-
GFP polyclonal antibody was obtained from Clontech; additionally,
we raised a rabbit anti-GFP antiserum after injection of purified
recombinant GFP in rabbits. BODIPY-TR-ceramide was from
Molecular Probes. [9, 10-3H]-Palmitic acid (40-60 Ci/mmol), [9, 10-
3H]-Myristic acid (40-60 Ci/mmol), Protein A-Sepharose and Cy3-
labeled anti-rabbit antibodies were from Amersham Pharmacia
Biotech. All other biochemicals used were of the highest purity
available and were obtained from regular commercial sources.
Construction of the GFP fusion proteins
The general design of the nine mutants described herein consisted of
N-terminal tags fused to the enhanced GFP using a BssHII site in the
pCDNA3 plasmid (Invitrogen, Barcelona, Spain) under the control
of the cytomegalovirus promoter. We performed recursive PCR in
order to obtain a de-novo-designed sequence using six overlapping
oligonucleotides and introducing a NcoI site at the 5′ end and a BssHII
site at the 3′ end of the desired sequence. This starting sequence,
referred to as linker-GFP, consisted of a consensus myristoylation
motif (MGCTLS) followed by the triplet AGS repeated nine times
followed by the GFP sequence, that is MGCTLS-(AGS)9-GFP (Fig.
1). Site-directed mutagenesis was employed in order to introduce the
desired mutations. In the case of the eNOS-GFP construct, we
amplified the first 55 residues of endothelial nitric oxide synthase,
introducing novel NcoI and BssHII sites at the 5′ and 3′ end,
respectively. This first 55 residues of eNOS include the myristoylation
site together with the two palmitoylated cysteines (Cys15 and Cys26)
and is enough to target GFP to Golgi regions and discrete regions of
the plasma membrane (Liu et al., 1997). PCR-amplified bands of all
the constructs were ligated into the pGEM-T vector (Invitrogen), and
they were subsequently sequenced. Owing to the presence of N oI and
BssHII sites in pCDNA3, we first double digested the Giα1(32 aa)-
GFP construct with EcoRI plus XbaI and ligated the excised fragment
into the corresponding sites of a pUC vector polylinker. All the
pGEM-T vectors with linker-GFP, G2A-GFP, C3S-GFP, G2A/C3S-
GFP, C3S/S9C-GFP, C3S/S15C-GFP, C3S/S21C-GFP and eNOS-
GFP were then double digested with NcoI plus BssHII, and the excised
band was subsequently ligated into the corresponding site of pUC-
Giα1(32 aa)-GFP. Finally, all the constructs in pUC were double
digested with EcoRI plus XbaI and the excised bands ligated in the
corresponding sites in pCDNA3. Finally, every plasmid was
sequenced to confirm the desired mutations.
Immunoblot analysis and cellular fractionation
Cellular proteins were resolved by 15% acrylamide SDS-PAGE and
transferred to nitrocellulose membranes. Western blots were
incubated for 2 hours in PBS containing 2% powdered skimmed milk.
Subsequently, the nitrocellulose membranes were incubated overnight
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with the primary antibodies (typically 1:1000 in PBS), washed and
finally incubated for 2 hours with a horseradish-peroxidase-
conjugated goat anti-rabbit antibody (Pierce). Detection was
performed using a ECL detection kit (Amersham Pharmacia Biotech).
Quantification of the intensity of the bands was performed using
a UViband V97 software (UVItec St. John’s Innovation Centre,
Cambridge, UK).
Fractionation was performed by harvesting the cells and
resuspending them in 0.4 ml of PBS supplemented with 1 mM
EDTA, 10 µg/ml aprotinin, 10 µg/ml leupeptin and 2 mM
phenylmethylsulfonyl fluoride (Sigma) as protease inhibitors. The
cellular suspensions were then passed several times through a syringe
(0.5×16 mm) and were further homogenized with short sonication
cycles (3×10 seconds each) on ice. Unbroken cells and cellular debris
were eliminated by a 10 minute centrifugation at 3000 g in a table-
top microcentrifuge. The samples were then centrifuged for 16 hours
at 200,000 g in a SW65 rotor (Beckman) at 4°C. The cellular pellets
(particulate fraction) and the supernatants (soluble fraction) were
brought up to equal volumes and subsequently analyzed by SDS-
PAGE followed by immunodetection with a rabbit anti-GFP antibody.
Metabolic labeling and immunoprecipitation
COS-7 cells transiently transfected with the desired construct were
starved for 1 hour with DMEM in the absence of any FBS 36 hours
after transfection. The monolayers were subsequently labeled for 4
hours with 200 µCi [9, 10-3H]-myristic acid or 200 µCi [9, 10-3H]-
palmitic acid. The radioactive compounds were dried completely
under nitrogen and resuspended initially in 10 µl of DMSO followed
by 1 ml of DMEM containing 2% dialyzed FBS plus 0.5% de-fatted
BSA (Sigma). The cells were washed with PBS, scraped and lysed in
Ripa buffer (10 mM Tris, 150 mM NaCl, 1% Triton X-100, 0.1% SDS,
0.1% deoxicholate, pH 7.35) in the presence of protease inhibitors.
After centrifugation of the cell lysate at 6000 g for 10 minutes at 4°C,
the supernatant was incubated with 10 µl of the rabbit anti-GFP
antibody. The mixture was incubated overnight at 4°C, and then
25 µl of a 1:1 suspension of Sepharose:Protein A-Sepharose beads
(Amersham Pharmacia Biotech) was added to each sample and the
incubation was maintained for 5 hours at 4°C. Immunoprecipitates
were centrifugated at 16,000 g in a table top microcentrifuge for 10
minutes, and the supernatant was removed. Immunoprecipitates were
then washed twice in 0.5 ml of ice-cold Ripa buffer. Samples were
separated by SDS-PAGE, and the gels were treated with Enhance
solution (Amersham Pharmacia Biotech) in order to improve the
radioactivity signal. The gels were dried in a BioRad vacuum
apparatus and exposed on photography films in a cassette for 4 weeks
at –80°C.
Confocal fluorescence microscopy
Transiently transfected COS-7 cells grown on 0.2% gelatin-coated
glass coverslips were washed two times with PBS and fixed for
15 minutes at room temperature with freshly prepared 2%
paraformaldehyde in PBS. The stock paraformaldehyde solution was
prepared at 4% in PBS and was centrifuged at 16,000 g for 5 minutes
at room temperature in a table-top microcentrifuge in order to remove
insoluble material prior to dilution. After removal of the 2%
paraformaldehyde solution, the cells were washed with PBS and
incubated with cold methanol at –20°C for 10 more minutes. The
methanol was removed, and the coverslips were allowed to dry for 5
minutes. Then, the cells were washed with PBS and the slides were
mounted using Fluoroguard anti-fade reagent (BioRad). The
subcellular localization was observed under a BioRad MRC-1024
confocal microscope equipped with two lasers using the excitation
wavelength of 488 nm for the GFP intrinsic fluorescence and 543 nm
for the Cy3 fluorophore and the BODIPY-TR-ceramide. Double
labeling was performed on transiently transfected COS-7 cells
permeabilized with methanol. Incubation with a rabbit polyclonal
anti-caveolin-1 antibody (Transduction) was done for 1 hour at 37°C
in a wet chamber. Next, the cells were washed with PBS and the anti-
rabbit Cy3-labeled secondary antibody was added. BODIPY-TR-
ceramide (1.5 µM in DMEM) staining was done in vivo in COS-7
transfected cells, and the reagent was added 30-60 minutes before
analysis of the double labeling under the confocal microscope. The
live cells were washed twice with PBS and examined for their
subcellular distribution. Fixing was avoided, since the methanol
significantly distorts the BODIPY-TR-ceramide signal. When the in
vivo fluorescence measurements were done (incubations with β-
m thylcyclodextrin), the cells were kept at 37°C using a Peltier
system, and Hepes buffer was used all throughout the experiment. The
cycloheximide treatment (100 µg/ml) was performed 24 hours post-
transfection for 2 hours at 37°C.
Preparation of caveolin-enriched low density membrane
fractions
Typically, four transiently transfected COS-7 confluent 75 cm2 flasks
were scraped and the cells resuspended into 2 ml (final volume) of
Mes buffered saline (MBS) (25 mM MES, pH 6.5, 0.15 M NaCl, 1
mM PMSF plus 1% Triton X-100) at 4°C. Isolation of the Triton-X-
100-insoluble fractions with a lower number of cells needed
the amount of detergent to be scaled down proportionally.
Homogenization of the cells was carried out with a minimum of 10
strokes through a syringe (0.5×16 mm) on ice. The homogenate was
then adjusted to 40% sucrose by the addition of 2 ml of 80% sucrose
prepared in MBS (4 ml in total), and it was placed at the bottom of a
Beckman SW40 13 ml Ultraclear tube. The discontinuous gradient
(40-30-5%) was formed by loading 4 ml of 30% sucrose followed by
4 ml of 5% sucrose always in MBS. Separation was performed at
200,000 g for 18 hours in a SW40 rotor (Beckman) at 4°C. A light
scattering band confined to the interface of the 5-30% sucrose region
was observed that contained the majority of the caveolin-1 protein and
excluded most of the cellular proteins. After centrifugation, 1 ml
fractions were collected from the bottom of the tube to yield a total of
12 fractions. After that, 1 ml of cold acetone was added to each tube
and the homogenous mixture was allowed to precipitate overnight at
4°C. The samples were centrifuged at 16,000 g in a microcentrifuge,
and the protein pellets were allowed to dry for 2 hours to assure the
complete elimination of acetone traces. The protein precipitates were
then analyzed by SDS-PAGE. In addition to caveolin-1, 5′-
nucleotidase, a GPI-anchored protein was also used as a protein
marker of caveolin-1-enriched low fluidity subdomains (Kenworthy
and Edidin, 1998). The amount of total protein in each fraction was
measured using a micro-Lowry method. In essence, we first incubated
the protein sample with 2.5 ml of reagent E (25 ml NaOH, 0.2 M plus
25 ml 4% carbonate mixed with 250 µl 1% copper sulfate and 250 µl
of 2% tartrate). After 10 minutes of reaction at room temperature, we
added 250 µl of Folin reagent and let the mixture stand for an
additional 30 minutes. Absorbance was determined at 750 and 500 nm,
and the values were interpolated in a calibration curve performed with
known quantities of bovine serum albumin.
Co-immunoprecipitation
Transiently transfected COS-7 cells were washed twice with PBS,
scraped and lysed with several strokes of a thin-gauge syringe in Ripa
buffer in the presence of protease inhibitors on ice. Samples were
clarified for 1 hour at 4°C using 20 µl of a 1:1 mixture of
Sepharose:Protein-A-sepharose. After clarification, the supernatants
were incubated with 10 µl of the primary antibody (anti-GFP or anti
caveolin-1) overnight at 4°C. Then, 20 µl of the Sepharose:Protein-
A-sepharose slurry was added and the mixture was incubated for 2
additional hours at 4°C. The samples were centrifuged in a table-top
microcentrifuge, and the immunoprecipitates were then washed twice
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in 0.5 ml of ice-cold Ripa buffer. The resin beads were subsequently
boiled in SDS-PAGE loading buffer and processed in a 15%
acrylamide gel. The SDS-PAGE gel was afterwards transferred to
nitrocellulose, and the membrane was probed with the desired
antibodies.
Results
Design, transient expression in COS-7 cells and
acylation of the tagged-GFP constructs
We created various constructs to address the intriguing
possibility that de novo-designed sequences can become
palmitoylated in vivo. In addition, we investigated whether
cellular palmitoylation is dependent on the distance of the
reactive cysteine from the N-terminus of the protein. With that
in mind, we envisaged a protein sequence with a myristoylation
consensus motif (MGCTLS) followed by a ‘palmitoylable’
cysteine residue, which could be progressively moved apart
from the myristoyl moiety (Fig. 1A). Fusion of this N-terminal
tag to the soluble GFP was expected to result in constructs
where the membrane-interacting properties, incorporation of
myristic and palmitic acids and subcellular localization is
dictated by the N-terminal extension (van’t Hof and Resh,
2000). A similar approach has been utilized for other acylated
proteins (Liu et al., 1997; Galbiati et al., 1999; McCabe and
Berthiaume, 1999; Martín-Belmonte et al., 2000; Michaelson
et al., 2001). We refer to the construct with the consensus
myristoylation site and a cysteine residue at position 3 as
‘linker-GFP’, and it was used as a template for various other
mutant constructs. By PCR mutagenesis we introduced an
alanine residue at position 2 (G2A-GFP mutant),
a serine residue at position 3 (C3S-GFP mutant),
the double mutant with alanine at position 2 plus
serine at position 3 (G2A/C3S-GFP mutant), and
three mutants with serine at position 3 and
cysteine at positions 9, 15 or 21 (C3S/S9C-GFP,
C3S/S15C-GFP and C3S/S21C-GFP mutants).
Additionally, we created a construct fusing the
first 55 residues of eNOS to GFP to be used
together with a Giα1(32 residues)-GFP plasmid
as positive controls of dual acylation with
myristic and palmitic acids. As expected,
transient transfection of COS-7 cells with the
various pCDNA3 plasmids containing the
chimeric GFP cDNAs resulted in similar level of
expression for all of the recombinant proteins
(Fig. 1B).
Metabolic radiolabeling of the GFP chimeras
was performed using [9, 10-3H]-myristic acid
or [9, 10-3H]-palmitic acid followed by
immunoprecipitation of the cell lysates with the
anti-GFP antibody (Fig. 1C). As expected,
GFP alone was neither myristoylated nor
palmitoylated, whereas every GFP chimera that
possessed the N-terminal Gly in the context of a
consensus myristoylation sequence (Ser residue
at position 6) efficiently incorporated myristic
acid (linker, C3S, C3S/S9C, C3S/S15C, C3S/
S21C and eNOS-GFP chimeras). Predictably,
mutation of Gly2 to Ala2 resulted in no myristic
acid incorporation (G2A-GFP and G2A/C3S-
GFP chimeras) (Fig. 1C). Efficient incorporation of palmitic
acid occurred in the constructs linker-GFP, C3S/S9C-GFP and
C3S/S15C-GFP as well as in the positive control eNOS-GFP
(in addition to the Giα1-GFP construct) (data not shown).
Under identical conditions, a faint band of radioactivity
appeared for the C3S/S21C-GFP chimera, which is indicative
of a very low level of incorporation of palmitate at position
21 (Fig. 1C). Quantification of this band using the UVI-band
software revealed that 18% of the linker-GFP construct had
been incorporated. Non-myristoylated mutant G2A-GFP was
unable to be palmitoylated in spite of the fact that it contains
a Cys residue at position 3. Consequently, efficient S-acylation
can occur at positions Cys3 (linker-GFP), Cys9 (C3S/S9C-
GFP), Cys15 (C3S/S15C-GFP) and in minimal amounts
at Cys21 (C3S/S21C-GFP) but always in previously
myristoylated polypeptides. Since the four ‘palmitoylable’
Cys residues (Cys3, Cys9, Cys15 and Cys21) were surrounded
by identical amino acids, we must conclude that only the
distance to the N-terminus of the GFP chimera is a
determinant for protein palmitoylation. We could rule out the
possibility that the lower incorporation of palmitic acid at
position 21 is caused by its proximity to the GFP sequence,
since 12 amino acids have been introduced between Cys21
and the first residue of GFP. Previous studies have shown that
cysteine residues located either five (Fyn kinase-GFP
construct) or seven amino acids from the GFP reporter
(GAP43-GFP construct) were efficiently palmitoylated
(McCabe and Berthiaume, 1999). Note that the myristoylated
C3S-GFP construct, which lacks any cysteine residue in the
linker region, is unable to become palmitoylated at any of the
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Fig. 1. Illustration of the linker-GFP construct with the location of the consensus
myristoylation sequence and the positions where the mutations were introduced (A),
expression of the recombinant proteins in COS-7 cells (B) and fatty acylation of the
GFP chimeras (C). By recursive PCR, the triplet AGS repeated nine times was
created following a consensus N-myristoylation sequence and fused in frame to the
GFP sequence. Mutations were introduced at Gly2, Cys3, Ser9, Ser15 and Ser21 in
various combinations, as described in the Materials and Methods (A). The different
linker-GFP constructs were inserted in a pCDNA3 vector that was used to transfect
COS-7 cells (B). Transfected COS-7 cells were starved for 1 hour in DMEM without
serum and were then metabolically labeled for 4 hours with either [3H]-myristic acid
(Myr) or [3H]-palmitic acid (Palm). Cell lysates were immunoprecipitated with an
anti-GFP antibody, analyzed by SDS-PAGE and exposed to a film as described in the
Materials and Methods. Identical results were obtained in two independent metabolic
labeling experiments.
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Cys residues present in the GFP sequence itself
(Cys48 and Cys70) (Fig. 1C).
Subcellular localization of the GFP
chimeras by confocal microscopy
To assess whether the N-terminal extensions
confer different subcellular localization
information, we transfected COS-7 cells with
the various GFP constructs and inspected their
distribution using laser confocal microscopy
(Fig. 2). The linker-GFP mutant displays a
plasma-membrane and focal perinuclear
localization with nuclear exclusion and low
cytosolic levels of fluorescence. This
phenotype contrasts with the subcellular
distribution of GFP alone, which produces both
cytosolic and a marked nuclear staining; thus
linker-GFP distribution strongly suggests that
the acylation of the linker-GFP construct is
responsible for the observed subcellular
targeting. Substitution of the Gly residue at
position 2 by Ala (G2A-GFP and G2A/C3S-
GFP chimeras), a mutation known to impede
myristoylation (Fig. 1C), restores the
widespread cytosolic and nuclear distribution,
with negative staining of nucleoli observed for
GFP alone. Elimination of the putative
palmitoylation site Cys3 and maintaining the
myristoylation site (C3S-GFP mutant) results
in a distribution characterized by the nuclear
exclusion and the loss of the plasma membrane
staining, with an enrichment in intracellular
membranes, in perinuclear vesicles as well as
in the ER (Fig. 2). The myristoylated and
palmitoylated GFP chimeras C3S/S9C,
C3S/S15C as well as the two positive controls
of dual acylation (Giα1 and eNOS) display a
similar staining to the linker-GFP construct;
that is, plasma membrane plus distinctive
intracellular vesicular organelles and a
complete nuclear exclusion. Finally, the
myristoylated C3S/S21C-GFP chimera, which
incorporates palmitic acid very poorly, exhibits
a mixed phenotype reflecting both the linker-
GFP and C3S-GFP construct localizations (Fig.
2).
Membrane partitioning of the GFP chimeras
To investigate the effect of the various acylation states on the
membrane partitioning of the GFP chimeras, we fractionated
the cellular lysates into Supernatant (S-soluble) and Pellet (P-
membrane-associated) fractions after ultracentrifugation at
200,000 g (Fig. 3). The presence of the GFP chimeras was
detected using specific antibodies, and the intensity of the
bands was accurately determined using a UViband V97
software. Constructs that did not incorporate either myristic or
palmitic acid, such as GFP, G2A-GFP and G2A/C3S-GFP,
were predominantly soluble. Dually acylated GFP chimeras,
such as linker, C3S/S9C, C3S/S15C, Giα1 and eNOS,
partitioned preferentially into the membrane-associated
fractions. (More than 65% of the chimeras were in membrane-
bound fractions; Fig. 3.) The construct C3S-GFP, which is
myristoylated but not palmitoylated, has approximately half of
its total immunoreactive protein in each fraction, and an almost
identical distribution is also observed in the case of the
C3S/S21C-GFP chimera. Therefore, as expected, N-terminal
myristoylation increases the overall hydrophobicity of the
engineered GFP chimeras, resulting in an increased association
with cellular membranes (roughly 50% in the P lane), whereas
the additive effect of myristoylation plus palmitoylation results
in the majority of the protein associating with the membrane
(Fig. 3).
Fig. 2. Subcellular localization of the various constructs characterized in the present
work as visualized by laser confocal microscopy. COS-7 cells were transfected with
the various constructs, and the fluorescence was analyzed 36 hours after transfection.
GFP fluorescence was visualized by confocal microscopy at an excitation wavelength
of 488 nm. Bar, 50 µm.
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Enrichment of the GFP chimeras in Triton-insoluble
membrane rafts
Owing to their elevated cholesterol and sphingolipids content,
caveolar membranes are resistant to extraction at 4°C by
nonionic detergents such as Triton X-100; instead they float on
bottom-loaded sucrose density gradients (Kurzchalia and
Parton, 1999; Simons and Toomre, 2000). We inspected the
targeting of the various acylated constructs to these low-fluidity
domains preparing 40:30:5% sucrose discontinuous gradients
in the presence of Triton X-100 following a well-defined
procedure (Lisanti et al., 1999). Caveolin-1, which is
endogenously expressed in COS-7 cells, together with 5′-
nucleotidase, a GPI-anchored protein, was used as a marker for
these Triton-X100-insoluble domains (Kenworthy and Edidin,
1998; Lisanti et al., 1999; Kurzchalia and Parton, 1999). Partial
(but not complete) localization of the GFP chimeras to these
caveolin-1-enriched domains was only observed for the dually
acylated constructs linker-GFP, C3S/S9C-GFP, C3S/S15C-
GFP, Giα1-GFP and eNOS-GFP (Fig. 4). The non-acylated
GFP, G2A-GFP and G2A/C3S-GFP proteins were found in
fractions 1 through 4 (bottom of the gradient), where most of
the cellular proteins were present (upper panel). Although both
the myristoylated C3S-GFP and C3S/S21C-GFP chimeras had
a certain tendency to float towards lower density fractions (they
were present in fractions 1 through 7), they were not
significantly enriched in fractions 8 and 9 accompanying
caveolin-1. Thus, the myristic acid moiety alone confers
membrane-interacting properties but not the capacity to fully
interact with the low-fluidity cholesterol-sphingomyelin
enriched domains. Additionally, we used the integrin β1, a
transmembrane protein known to be excluded from Triton-
X100-insoluble rafts (Nusrat et al., 2000) as a specific marker
of membrane-associated but caveolae-excluded protein.
Integrin β1 is concentrated in high-density fractions (40%
sucrose, fractions 1-4) at the bottom of the tube (Fig. 4).
Confocal microscopy colocalization studies of the GFP
chimeras with caveolin-1 in transfected COS-7 cells
Next, we investigated whether the subcellular localization of
the various GFP chimeras transfected in COS-7 cells partially
overlapped with that of endogenous caveolin-1 (Fig. 5A).
Transiently transfected COS-7 cells were permeabilized and
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Fig. 3. Subcellular fractionation of COS-7 cells expressing the
various GFP constructs. Transfected COS-7 were lysed and after
clarification of the cellular debris by centrifugation were fractionated
into supernatant (S) and pellet (P) fractions by ultracentrifugation for
16 hours at 200,000 g as described in the Materials and Methods.
The fractions were subjected to SDS-PAGE, analyzed by western
blot with an antibody against GFP, and the resulting bands were
quantified using UVIband V97 software. These results are
representative of a minimum of five independent fractionations, with
less than 5% variation among different experiments.
Fig. 4. Sucrose flotation gradients in the presence of Triton X-100.
COS-7 cells transfected with the GFP-tagged constructs were
extracted in the presence of Triton X-100 at 4°C and subjected to
centrifugation on a 40:30:5% sucrose gradient as described in the
Materials and Methods. After centrifugation, the gradient tubes were
divided into 12 equal aliquots collected from the bottom and
analyzed by SDS-PAGE and western blotting. The amount of protein
in each sample was determined using a micro-Lowry method (upper
panel; average distribution). Similar results were obtained in four
independent experiments.
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incubated with anti-caveolin-1 antibodies.
The three mutant GFP chimeras shown on
Fig. 5A, linker-GFP, G2A-GFP and C3S-
GFP, are representative of each of the well
defined phenotypes. Taking advantage of
the GFP intrinsic fluorescence, together
with signal emitted from the Cy3-labeled
secondary antibodies, we inspected the
colocalization of the three chimeras with
caveolin-1 that are present endogenously in
COS-7 cells. Caveolin-1 staining was
mostly focal and punctate, and it could be
observed in regions close to the plasma
membrane and to a lesser degree in
intracellular aggregates; it was always
excluded from the cell nucleus (Fig. 5,
middle panels). When merged with the
GFP signal (Fig. 5, right panels; see also
supplemental data), there was a significant
overlap (yellow) in distribution with the
linker-GFP and G2A-GFP chimeras at
areas close to the plasma membrane
(arrows) and no overlap with the C3S
chimera. However, the dually acylated
mutant linker-GFP still exhibited extensive
GFP fluorescence in cytosolic regions
where the caveolin-1 fluorescence was
excluded. A similar codistribution with
caveolin-1 in the plasma membrane and
adjacent areas (caveolae) was observed for
the other dually acylated GFP chimeras
(data not shown). The coincidence in the
fluorescence signal of the G2A-GFP
chimera with caveolin-1 was somehow
expected, since this mutant presents GFP
fluorescence in the entire cytoplasm and
nucleus. Interestingly, the merge of the
myristoylated, non-palmitoylated C3S-
GFP chimera signal with that of caveolin-
1 reveals a crown-like distribution.
Whereas caveolin-1 distribution is centered
on plasma membrane areas, the C3S-GFP
fluorescence is selectively excluded from
them.
Intriguingly, dually acylated N-terminal
segments of Giα1 could still associate with
caveolin-1 and translocate to the plasma
membrane in spite of the fact that they lack
the caveolin-1-interacting motif (Galbiati
et al., 1999). To determine whether
the targeting to Triton-X100-insoluble
domains as well as the localization of our
tagged GFP constructs to caveolae
coincided with a physical interaction
between the recombinant proteins and
caveolin-1, we performed co-
immunoprecipitation experiments (Fig.
5B). Immunoprecipitation of linker-GFP or C3S-GFP
transiently transfected COS-7 cells with anti-caveolin-1
antibodies, and analysis of the immunoprecipitate with anti-
GFP antibodies failed to reveal any positive interaction.
Nevertheless, we were able to detect caveolin-1 as well as a
caveolae-associated protein (the α subunit of Gq) in caveolin-
1-immunoprecipitated COS-7 cells (Fig. 5B, left panel).
Likewise, when we immunoprecipitated linker-GFP or C3S-
Fig. 5. Colocalization studies of linker-GFP, G2A-GFP and C3S-GFP with caveolin 1.
COS-7 cells were transfected with the linker-GFP (upper panels), G2A-GFP (middle
panels) or C3S-GFP (lower panels) constructs and analyzed 36 hours post-transfection
(A). The GFP fluorescence (left panels) was obtained after excitation at 488 nm, whereas
the Cy3 fluorescence (middle panels) was obtained after excitation at 543 nm. The right
panels show the merge of both fluorescence signals. Bar, 50 µm. The physical interaction
of caveolin-1 with the GFP chimeras was analyzed in pull-down experiments (B). COS-7
cells transfected with the linker-GFP construct, C3S-GFP construct or mock-transfected
were lysed and immunoprecipitated with anti-caveolin-1 antibodies (left panel) or with
anti-GFP antibodies (right panel) as described in the Materials and Methods. The
immunoprecipitated samples were then analyzed (immunodetected, I.D.) with anti-GFP,
anti-caveolin-1 or anti-Gqα antibodies as outlined in the figure.
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GFP-transfected COS-7 cells with anti-GFP
antibodies, identification of caveolin-1
association in the immunoprecipitate was
unsuccessful (Fig. 5B, right panel). By
contrast, experiments performed in parallel
confirm that the immunoprecipitation of the
GFP constructs was successful. Hence, the
most likely explanation for our results is that
dual acylation per se partially targets the
GFP reporter to caveolae owing to the
intrinsic low-fluidity properties of this
cholesterol-sphingomyelin-enriched do-
main, rather than to a physical interaction
with caveolin-1 in COS-7 cells.
Colocalization of chimeric GFPs with
the Golgi compartment
To assess whether the various N-terminal
fatty acylated sequences contain different
subcellular information that might target
the GFP chimeras to the Golgi apparatus,
we used BODIPY-Texas Red-ceramide in
vivo as a marker. The intrinsic fluorescence
of the linker-GFP, G2A-GFP and C3S-GFP
chimeras in living cells together with the
Golgi staining is shown in Fig. 6.
Internalization of this Golgi marker occurs
via endocytosis, and some of the endosome
and areas of the trans Golgi network can
display partial labeling, particularly in our
in vivo staining. The three GFP-tagged
constructs colocalize with the Golgi marker
in intracellular membranes adjacent to the
nucleus (Fig. 6A, right panels).
Colocalization of the linker-GFP chimera
with BODIPY-TR-ceramide is more
apparent in perinuclear regions, although
partial overlap can also be observed in
certain endocytic regions in the proximity
of the plasma membrane. On the other
hand, the broad distribution of the G2A-
GFP fluorescence in the entire cytosol and
nucleus without any specific staining
invalidates any positive colocalization with
the Golgi marker. Mutant C3S-GFP
exhibits a clear overlap with BODIPY-TR-
ceramide, which indicates that the
myristoylation observed for this mutant
results in Golgi targeting. Additionally, we
inspected the phenotype adopted by the
linker-GFP and C3S-GFP chimeras upon incubation with
cycloheximide for 2 hours (Fig. 6B). In both cases, the total
fluorescence observed diminishes. Significantly, in the dually
acylated linker-GFP construct, the plasma-membrane-
associated signal is considerably less affected than the Golgi
localization. Hence, this Golgi pool probably reflects a
biosynthetic intermediate of the linker-GFP mutant along the
secretory pathway en route to the caveolae-associated plasma
membrane subdomains. In the case of the C3S-GFP mutant,
the Golgi staining becomes significantly reduced, whereas
some ER-associated perinuclear staining is still observed (Fig.
6B).
Changes induced in the subcellular localization of the
GFP chimeras induced by cholesterol depletion and by
2-bromopalmitate treatment
We also investigated whether in vivo cholesterol depletion with
β-methyl cyclodextrin alters the plasma membrane targeting of
the dually acylated chimera linker-GFP (Fig. 7). Inspection of
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Fig. 6. Colocalization studies of linker-GFP, G2A-GFP and C3S-GFP with the Golgi
marker BODIPY-TR-ceramide (A) and cycloheximide treatment of the linker-GFP and
C3S-GFP chimeras (B). (A) COS-7 cells were transfected with the linker-GFP (upper
panels), G2A-GFP (middle panels) or C3S-GFP (lower panels) constructs and, 36 hours
post-transfection, they were incubated with the Golgi apparatus marker BODIPY-Texas
Red-ceramide (1.5 µM in DMEM). The GFP fluorescence (left panels) was obtained after
excitation at 488 nm whereas the Texas Red fluorescence (middle panels) was obtained
after excitation at 543 nm. Right panels show the merge of both fluorescence signals. Bar,
50 µm. (B) Changes induced in the localization of the linker-GFP and C3S-GFP mutants
upon treatment with 100 µg/ml cycloheximide for 2 hours. The treatment was performed
24 hours post-transfection.
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the changes arising from cholesterol removal in COS-7 cells
36 hours post-transfected with the linker-GFP chimera
revealed that after 10 minutes of incubation with β-methyl
cyclodextrin, the GFP fluorescence associated with the plasma
membrane was altered (Fig. 7B). Examination of the live COS-
7 cells at 20 and 30 minutes after treatment (Fig. 7C,D) allows
us to conclude that a redistribution of the caveolar targeting of
the mutant is taking place owing to the
sequestration of cholesterol. Whereas the
perinuclear Golgi staining remains basically
unaffected by treatment for 30 minutes with the
reagent, most of the plasma membrane
localization of the myristoylated and
palmitoylated mutant is profoundly modified
(Fig. 7D, arrows). Thus, after dual acylation and
partial translocation to plasma membrane
subdomains, the integrity of the cholesterol-
sphingomyelin rafts appears to be requisite for the
correct caveolar association of the dually acylated
construct.
Recently, 2-bromopalmitate was reported to be
an effective inhibitor of protein palmitoylation in
vivo (Webb et al., 2000). Therefore, we used this
reagent to further confirm the role of
palmitoylation in the membrane targeting of the
dually acylated GFP chimeras (Fig. 7E-J). As
expected, the linker-GFP, C3S/S9C-GFP and
C3S/S15C-GFP chimeras were significantly
affected by the 2-bromopalmitate treatment,
resulting in phenotypes that strongly resembled
that of the C3S-GFP chimera, with most of the
plasma membrane localization being lost. The
G2A-GFP and C3S-GFP chimeras remained
unaffected by the treatment (Fig. 7), as did the
G2A/C3S-GFP construct (data not shown).
Intriguingly, the reagent also affected the
fluorescence associated with intracellular
membranes, resulting in increased vacuolization,
which lead to the appearance of small vesicles
that display trapped GFP fluorescence. This
phenotype could be observed both in the singly
myristoylated (C3S-GFP, C3S/S21C-GFP) as
well as in the dually acylated chimeras and very
probably reflects some collateral metabolic
alteration induced by 2-bromopalmitate
treatment. However, treatment of COS-7 cells
with bromopalmitate or methyl-cyclodextrin
under identical conditions did not affect the
plasma membrane staining of integrin α3β1, a
protein known to be excluded from rafts/caveolae
(data not shown).
Discussion
In general, myristoylated cellular proteins,
although more hydrophobic than their non-
myristoylated counterparts, have barely enough
energy to translocate from the cytosol to the inner
leaflet of the plasma membrane. In this regard, a
10–4 M effective dissociation constant calculated
for myristoylated peptides and liposomes was
deduced from the 8 kcal/mol energy requirement needed to
carry out this process (Peitzsch and McLaughlin, 1993).
Consequently, in order to bind tightly to membranes,
myristoylated proteins are often palmitoylated or possess basic
or apolar residues at their N-terminus that promote their
interaction with lipids (Milligan et al., 1995; Dunphy and
Linder, 1998; Resh, 1999; McCabe and Berthiaume, 1999).
Fig. 7. In vivo changes in the subcellular localization of the linker-GFP construct
upon cholesterol depletion using β-methyl cyclodextrin and changes in the
subcellular localization of various GFP chimeras upon incubation with 2-
bromopalmitate. COS-7 cells were transfected with the linker-GFP plasmid and
incubated with 10 mM β-methyl cyclodextrin for 0, 10, 20 or 30 minutes (A-D) at
36 hours after transfection. Arrows in D denote changes in the plasma membrane
fluorescence. COS-7 cells were also transfected with the linker-GFP, G2A-GFP,
C3S-GFP, C3S/S9C-GFP, C3S/S15C-GFP or C3S/S21C-GFP plasmids and, 36
hours post-transfection, incubated with 25 µM 2-bromopalmitate for 16 hours (E-J).
Bar, 50 µm.
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Although some myristoylated proteins possess free sulfhydrils
alongside its primary sequence, only the cysteines located at
the N-terminus of the protein incorporate palmitic acid.
Interestingly, palmitoylation of previously myristoylated
proteins often leads to the translocation of the dually acylated
protein to cholesterol-sphingomyelin-enriched subdomains
(Dunphy and Linder, 1998; Resh, 1999; Melkonian et al., 1999;
Galbiati et al., 1999).
To date, the mechanisms underlying cellular protein
palmitoylation have remained elusive despite the significant
number of identified proteins that are post-translationally
modified through the attachment of a palmitic moiety to the
side chain of a cysteine residue. Unlike the well characterized
myristoylation motif recognized by the enzyme N-myristoyl
transferase, inspection of the N-terminus of dually acylated
proteins reveals that no clear consensus sequence exists for a
certain protein for S-acylation with palmitic acid. Although
some palmitoylated cysteine residues are in the proximity of
basic residues (for example, in Hck and Fgr kinases and Gαz),
a few others are close to Ser or Thr residues (for example, in
Lck kinase, Gα i1, Gα0 and Vac8p) or hydrophobic residues
(Fyn, Lyn and Yes kinases, AKAP18, MPSK and eNOS).
Remarkably, myristoylation is frequently a prerequisite for a
dually acylated protein to become palmitoylated, since
elimination of the myristic acid aceptor residue, Gly2,
abrogates subsequent palmitoylation (Koegl et al., 1994;
McCabe and Berthiaume, 1999; Galbiati et al., 1999). The
putative existence of a unique cellular palmitoyl transferase
presupposes that this enzyme must recognize cysteine residues
inserted within different amino acid motifs before catalyzing
the addition of palmitate from palmitoyl-CoA. Moreover, this
enzyme should selectively recognize a very vague sequence
motif present only in a myristoylated substrate and
subsequently transfer palmitic acid to the thiol group of a
proximal Cys residue. Conversely, multiple palmitoyl
transferases might exist, each with a different cellular
substrate, implicated individually in the tight regulation of the
activity of one dually acylated protein, many of which are
involved in signaling processes (Milligan et al., 1995; Dunphy
and Linder, 1998; Simons and Toomre, 2000; Janes et al.,
2000).
However, since the palmitoylation-depalmitoylation
recycling of proteins is a strictly regulated process, one can
envisage that this cycle might be controlled at the
depalmitoylation level (Dunphy and Linder, 1998; Resh,
1999). Interestingly, a cytoplasmic acyl-protein thioesterase
(APT-1) that removes palmitate from G protein α subunits,
p21Ras and eNOS has been recently identified (Duncan and
Gilman, 1998; Yeh et al., 1999), although the cellular
mechanisms of regulation of this esterase remain to be
established. Since APT-1 also hydrolyzes both free palmitoyl-
CoA and palmitic acid covalently bound to proteins, it is
conceivable that an increase in cellular APT-1 activity is
accompanied by both diminished protein palmitoylation and
augmented protein depalmitoylation. Nevertheless, further
experiments seem necessary in order to analyze the cellular
mechanisms that regulate protein acylation.
In this study, we have analyzed whether de-novo-designed
sequences fused to the GFP reporter become effectively
palmitoylated in vivo. Two other dually acylated GFP-tagged
chimeras - Giα1 and eNOS - were used as positive controls.
In the absence of hydrophobic residues, polybasic signals or
prenylation sites, the palmitoylation of a Cys residue inserted
in the linker-GFP chimera is a direct consequence of its
reactivity towards cellular palmitoyl transferases (enzymatic
palmitoylation) or its direct interaction with Pal-CoA (non-
enzymatic palmitoylation). Efficient palmitoylation was
observed at Cys3, Cys9, Cys15 and marginally at position
Cys21, which is indicative that (i) palmitoylation can
efficiently occur in a de novo-designed sequence, (ii) this
process is dependent on the proximity of the reactive thiol to
the N-terminus of the protein and (iii) palmitoylation only
takes place on sequences that were previously myristoylated.
The degree of palmitoylation observed was similar to the one
displayed by the eNOS-GFP chimera under identical pulse
treatment (Fig. 1C). It is interesting, in this context, to note
th t eNOS becomes N-terminally myristoylated and
subsequently palmitoylated at positions Cys15 and Cys26
(Liu et al., 1995; Robinson et al., 1995). However, the
presence of multiple hydrophobic residues in the proximity
of these palmitoylated cysteine residues are probably
responsible for the attachment of the palmitate in such distant
positions, since mutagenesis of the five Leu residues present
within residues 16 and 25 of eNOS abrogate palmitoylation
(Liu et al., 1997).
According to our data, myristoylation is a prerequisite for
protein palmitoylation (Fig. 1C), mimicking the well known
dependence of S-acylation on prior membrane association via
myristoyl, prenyl or transmembrane peptide moieties (Dunphy
and Linder, 1998; Resh, 1999). Whereas N-terminal
myristoylation is enough to induce the nuclear exclusion and
partial intracellular membrane association of the GFP reporter,
dually acylated proteins are excluded from the cell nucleus and
localize to intracellular Golgi membranes and partially to the
plasma membrane (Fig. 2). Although both myristoylation and
palmitoylation individually increased the partitioning of the
proteins into membranous fractions, the dually acylated
proteins were found almost uniquely in the particulate fractions
(Fig. 3). The increased hydrophobicity provided by both post-
translational acylations resulted in augmented interaction with
cellular membranes, although only palmitoylation conferred on
the GFP chimeras the ability to translocate towards cholesterol-
sphingomyelin-enriched domains, in accordance with the
proposed role of palmitoylation and caveolae localization (Figs
4 and 5). Indeed, plasma membrane staining of the dually
acylated, but not the myristoylated, GFP chimeras provides
support for the unique lipid-interacting properties endowed by
the palmitic moiety (Fig. 5). Since our constructs lack the
consensus caveolin-1-interacting motif (Couet et al., 1997), it
must be concluded that palmitate per se conveys on the N-
t rminal tag the ability to interact with Triton-insoluble, low-
fluidity domains. Significantly, in spite of the colocalization
with caveolin-1 in plasma membrane locations (Fig. 5), dually
acylated chimeras were unable to physically interact with
caveolin-1. This lack of physical interaction with caveolin-1
has also been observed in short stretches of dually acylated
kinases fused to the GFP reporter as well (McCabe and
Berthiaume, 2001).
N-terminal myristoylation was sufficient to colocalize the
GFP chimeras with the Golgi marker BODIPY-TR-ceramide,
whereas dual acylation lead to both Golgi targeting and partial
colocalization with caveolin-1 (Figs 5 and 6). The coincidence
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with the caveolin-1 staining for our myristoylated plus
palmitoylated chimeras occurs mostly in the proximity of the
plasma membrane, although, as expected (Luetterforst et al.,
1999), some Golgi staining could also be observed. Further
demonstration of the localization of the dually acylated
constructs to Triton-insoluble membrane subdomains was
achieved using the cholesterol-sequestering agent β-methyl-
cyclodextrin and 2-bromopalmitate, a known inhibitor of
cellular palmitoylation (Fig. 7).
Interestingly, recent studies carried out with surfactant
protein C, a small protein that contains a polar palmitoylated
segment followed by a long transmembrane stretch, have
demonstrated that S-acylation is strongly dependent on the
distance of the palmitoylable cysteine residue from the
hydrophobic transmembrane α-helix (ten Brinke at al., 2002).
In this context, cysteine residues that are positioned in
proximity to the transmembrane domain are more efficiently
palmitoylated than those separated by a greater distance.
Finally, although our data cannot rule out the existence of
cellular palmitoyl transferase activities, they are consistent
with the hypothesis that certain cellular proteins are non-
enzymatically S-acylated, especially if the reactive cysteine
thiol is in the proximity of the membrane environment owing
to a previous lipidic modification (myristoylation or
prenylation). In our case, if palmitoylation was the result of an
enzymatic activity, we must then assume that a cellular
palmitoyl-transferase is able to recognize a non-cellular N-
terminal sequence (designed de novo). Alternatively, since
approximately 10% of the cellular palmitoyl-CoA is bound to
membranes in COS-7 cells (Bañó et al., 1998), it is then
conceivable that the direct transfer of palmitate to a reactive
cysteine residue might take place. The recent discovery that Src
family tyrosine kinases, Gα subunits, GAP43 and Ras can
become heterogeneously acylated on cysteine residues with
fatty acids other than palmitate (Liang et al., 2001) also
supports the suggestion that non-enzymatic palmitoylation of
proteins might be occurring within cells. Since the thiol of a
cysteine is a good nucleophile, the selective incorporation of
one fatty acid over the other might depend on the availability
of the specific membrane-bound acyl-CoAs in the proximity of
the reactive cysteine.
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